Zevra Therapeutics
ZVRA
ZVRA
77 hedge funds and large institutions have $63.1M invested in Zevra Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.63% less ownership
Funds ownership: 22.27% → 20.64% (-1.6%)
14% less capital invested
Capital invested by funds: $73.1M → $63.1M (-$10M)
Holders
77
Holding in Top 10
–
Calls
$19.2M
Puts
$11.8M
Top Buyers
| 1 | +$2.4M | |
| 2 | +$327K | |
| 3 | +$313K | |
| 4 |
MTIM
Marathon Trading Investment Management
Radnor,
Pennsylvania
|
+$295K |
| 5 |
D.E. Shaw & Co
New York
|
+$207K |
Top Sellers
| 1 | -$3.73M | |
| 2 | -$3.48M | |
| 3 | -$1.28M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.03M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$952K |